Project Details
Description
Project Summary
The rising incidence of multi-drug- and extensively drug-resistance strains of Mycobacterium tuberculosis
(Mtb), which causes tuberculosis (TB), threatens the efficacy of our current therapeutic arsenal. Thus, the
WHO strategic plan to eliminate TB emphasizes the development of new drugs. Processes within the cell
envelope are attractive as potential novel drug targets because Mtb modulates metabolic activities within the
cell envelope in response to environmental changes during infection, and these adaptations are essential to
Mtb viability and pathogenesis. However, our exploration of cell envelope pathways is constrained by our
limited knowledge of protein localization and function in the cell envelope and the lack of tools with which to
interrogate them. The objective of this application is to overcome this obstacle by developing a labeling
methodology that can be targeted to specific subcellular compartments, including the cell envelope. The
rationale is that new tools to study protein localization and interactions will allow us to, for the first time, (1)
accurately inventory the cell envelope proteome and (2) interrogate protein-protein interactions in the cell
envelope. Our innovation is to apply a live-cell protein labeling method that has not, to our knowledge, been
applied to mycobacteria. In contrast to existing methods, this approach preserves cellular architecture and
native protein interactions. From our preliminary studies we have evidence that the method will be successful
in our achieving our goals in mycobacteria. We therefore propose to characterize the non-canonical secreted
proteome of Mtb and elucidate the interactome of a putative non-canonical secreted protein that is essential for
cell growth in division. As a result of these studies we will have novel techniques to study cell envelope
proteins and will gain insight into protein localization and interactions that contribute to Mtb growth and
adaptation. These results are anticipated to have a positive impact on the evaluation of cell envelope proteins
as targets for anti-tuberculosis therapy and to advance our fundamental knowledge of mycobacterial cell
envelope processes and pathways.
| Status | Finished |
|---|---|
| Effective start/end date | 06/3/16 → 05/31/19 |
Funding
- National Institute of Allergy & Infectious Disease: $435,646.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.